Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seelos Therapeutics Inc (NQ: SEEL ) 0.5235 -0.0106 (-1.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Seelos Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 10, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday July 10, 2024 Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning! Via InvestorPlace Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket July 10, 2024 Via Benzinga 3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers July 08, 2024 These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases. Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session June 07, 2024 Via Benzinga SEEL Stock Earnings: Seelos Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 17, 2024 It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday! Via InvestorPlace SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023 March 22, 2024 SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 20, 2024 Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 20, 2024 Via Benzinga Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results March 19, 2024 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow traded up 0.63% to 39,034.59 while the NASDAQ rose 0.35% to 16,160.20. The... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session March 19, 2024 Via Benzinga Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results March 19, 2024 U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.54% to 39,001.22 while the NASDAQ fell 0.34% to 16,048.51. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 19, 2024 Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Via Benzinga Nasdaq Down 100 Points; US Housing Starts Surge In February March 19, 2024 U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.11% to 38,831.86 while the NASDAQ fell... Via Benzinga Topics Stocks Exposures US Equities CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why March 19, 2024 Seelos Therapeutics updates Phase 2/3 HEALEY ALS trial with SLS-005, showing potential efficacy in subgroup analysis. Explore the latest data on ALS treatment with SLS-005." Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More February 15, 2024 Via Benzinga Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More January 27, 2024 New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... Via Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. Via Benzinga Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More January 12, 2024 Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 12, 2024 Via Benzinga Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution January 09, 2024 Psychedelic stocks have been making big moves beneath the surface, and the sector's popularity might spark again in 2024. Via InvestorPlace Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More January 07, 2024 Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Via Benzinga Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More December 27, 2023 President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also... Via Benzinga Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More December 18, 2023 Biden To Decide On Psychedelic Therapy Bill Via Benzinga Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More December 11, 2023 John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy Via Benzinga Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 05, 2023 Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.